NO20072393L - P13-kinase gamma hemmere for behandling av anemi - Google Patents

P13-kinase gamma hemmere for behandling av anemi

Info

Publication number
NO20072393L
NO20072393L NO20072393A NO20072393A NO20072393L NO 20072393 L NO20072393 L NO 20072393L NO 20072393 A NO20072393 A NO 20072393A NO 20072393 A NO20072393 A NO 20072393A NO 20072393 L NO20072393 L NO 20072393L
Authority
NO
Norway
Prior art keywords
anemia
treatment
kinase
inhibitors
gamma inhibitors
Prior art date
Application number
NO20072393A
Other languages
English (en)
Inventor
Christian Rommel
Reinhard Wetzker
Angelika Mueller
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20072393L publication Critical patent/NO20072393L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Den foreliggende oppfinnelsen vedrører anvendelse av selektive P13-kinase ?-hemmere for fremstillingen av et medikament for behandling av lidelser på grunn av erytrocyttsvikt. Mer spesifikt angår oppfinnelsen bruken av selektive P13-kinase ?-hemmere, for eksempel substituerte azolidinonvinylkondenserte benzenderivater med formel I hvor A, X, Yl, Y2, X, N, R1 og R2 er som detaljert beskrevet i den etterfølgende beskrivelsen for behandlingen av en anemi, inklusive hemolytisk anemi, aplastisk anemi og ren rødcelleanemi.
NO20072393A 2004-10-12 2007-05-09 P13-kinase gamma hemmere for behandling av anemi NO20072393L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04104997 2004-10-12
PCT/EP2005/055156 WO2006040318A2 (en) 2004-10-12 2005-10-11 Pi3 kinase gamma inhibitors for the treatment of anaemia

Publications (1)

Publication Number Publication Date
NO20072393L true NO20072393L (no) 2007-05-09

Family

ID=34929693

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072393A NO20072393L (no) 2004-10-12 2007-05-09 P13-kinase gamma hemmere for behandling av anemi

Country Status (14)

Country Link
US (1) US20090042773A1 (no)
EP (1) EP1807075A2 (no)
JP (1) JP2008515955A (no)
KR (1) KR20070073857A (no)
CN (1) CN101056633A (no)
AU (1) AU2005293556A1 (no)
BR (1) BRPI0517416A (no)
CA (1) CA2580480A1 (no)
EA (1) EA200700848A1 (no)
IL (1) IL182110A0 (no)
MX (1) MX2007004302A (no)
NO (1) NO20072393L (no)
WO (1) WO2006040318A2 (no)
ZA (1) ZA200702435B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0515627A (pt) * 2004-09-03 2008-07-29 Applied Research Systems derivado de azolidinona de metileno de piridina, uso de derivado de azolidinona de metileno de piridina, composição farmacêutica, processo para o preparo de derivado de azolidinona de metileno de piridina e composto
EP2046333A4 (en) * 2006-07-24 2010-09-15 Glaxosmithkline Llc THIOZOLIDINEDIONE DERIVATIVES AS INHIBITORS OF P13-KINASE
WO2009017822A2 (en) 2007-08-02 2009-02-05 Amgen Inc. Pi3 kinase modulators and methods of use
WO2009085230A1 (en) 2007-12-19 2009-07-09 Amgen Inc. Inhibitors of pi3 kinase
US8268834B2 (en) 2008-03-19 2012-09-18 Novartis Ag Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
EP2341052A4 (en) * 2008-09-05 2011-10-12 Shionogi & Co RING-CONDENSED MORPHOLINE DERIVATIVITY WITH PI3K-INHIBITING EFFECT
EP2412710A4 (en) * 2009-03-27 2012-08-08 Kowa Co CONDENSED PIPERIDINE COMPOUND AND PHARMACEUTICAL AGENT CONTAINING THE SAME
EP2440556A1 (en) * 2009-06-10 2012-04-18 Vertex Pharmaceuticals Incorporated Inhibitors of phosphatidylinositol 3-kinase
UY33199A (es) * 2010-01-26 2011-08-31 Boehringer Ingelheim Int 5-alquinil-pirimidinas.
US8609672B2 (en) 2010-08-27 2013-12-17 University Of The Pacific Piperazinylpyrimidine analogues as protein kinase inhibitors
CN102584809B (zh) * 2011-01-14 2014-12-24 湘北威尔曼制药股份有限公司 胺基噻唑烷酮化合物及其制备方法与在制备抗肿瘤药物中的应用
AU2012245344B2 (en) 2011-04-22 2017-11-09 Jasco Pharmaceuticals, LLC Aminopyrimidine kinase inhibitors
US8927525B2 (en) 2011-11-04 2015-01-06 Jasco Pharmaceuticals, LLC Aminopyrimidine kinase inhibitors
MY170922A (en) 2011-12-22 2019-09-18 Novartis Ag Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
JP6454727B2 (ja) 2014-04-24 2019-01-16 ノバルティス アーゲー ホスファチジルイノシトール３−キナーゼ阻害薬としてのアミノピリジン誘導体
EA033571B1 (ru) 2014-04-24 2019-11-06 Novartis Ag Производные пиразина в качестве ингибиторов фосфатидилинозитол 3-киназы
KR20160141855A (ko) 2014-04-24 2016-12-09 노파르티스 아게 포스파티딜이노시톨 3-키나제 억제제로서의 아미노 피라진 유도체
FI3781561T3 (fi) 2018-04-18 2024-06-13 Constellation Pharmaceuticals Inc Metyyliä muuntavien entsyymien modulaattoreita, niiden koostumuksia ja käyttöjä
US11919912B2 (en) 2018-05-21 2024-03-05 Constellation Pharmaceuticals, Inc. Modulators of methyl modifying enzymes, compositions and uses thereof
JPWO2022163843A1 (no) * 2021-02-01 2022-08-04

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI240627B (en) * 1996-04-26 2005-10-01 Chugai Pharmaceutical Co Ltd Erythropoietin solution preparation
CA2493843C (en) * 2002-07-10 2012-04-17 Applied Research Systems Ars Holding N.V. Azolidinone-vinyl fused-benzene derivatives
ES2315566T3 (es) * 2002-11-22 2009-04-01 Smithkline Beecham Corporation Tiazolidin-4-onas para inhibir proteinas hyak3.

Also Published As

Publication number Publication date
IL182110A0 (en) 2007-07-24
EA200700848A1 (ru) 2007-10-26
US20090042773A1 (en) 2009-02-12
WO2006040318A3 (en) 2006-08-10
CA2580480A1 (en) 2006-04-20
EP1807075A2 (en) 2007-07-18
JP2008515955A (ja) 2008-05-15
AU2005293556A1 (en) 2006-04-20
CN101056633A (zh) 2007-10-17
WO2006040318A2 (en) 2006-04-20
ZA200702435B (en) 2008-06-25
BRPI0517416A (pt) 2008-10-07
KR20070073857A (ko) 2007-07-10
MX2007004302A (es) 2007-06-07

Similar Documents

Publication Publication Date Title
NO20072393L (no) P13-kinase gamma hemmere for behandling av anemi
NO20045486L (no) Nye forbindelser og deres anvendelse
NO20062335L (no) Nye diazaspiroalkaner og deres anvendelse i behandlingen av CCR8 medierte sykdommer
NO20044826L (no) Pyrrolidinderivater
NO20060001L (no) Nye P2X7-reseptorantagonister og deres anvendelse
NO20063599L (no) Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
NO20050828L (no) lndol-3-svovelderivater
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20063470L (no) Tetrazolforbindelser og deres anvendelse av metabotrofe glutamatreseptorantagonister
NO20054905L (no) 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
NO20050088L (no) Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav
NO20051826L (no) Heterosyklisk substituerte piperaziner for behandling av schizofreni
NO20075624L (no) Nye histamin H3-reseptorligander og deres terapeutiske anvendelser
NO20071108L (no) Nye 4-benzylidenpiperidinderivater
NO20054312L (no) HIV-replikasjonsinhiberende pyrimidiner og triaziner
NO20075158L (no) Nye sykliske aminer
NO20071593L (no) Pyrimidinderivater
NO20066055L (no) Pyridinderivater
NO20072689L (no) Tetrasykliske indolderivater som antivirale midler
NO20060324L (no) [1,8]Naftyridin-2-oner og relaterte forbindelser for behandling av Schizofreni
NO20071504L (no) Pyrimidinderivanter.
NO20051223L (no) Oksadiazoler som modulatorer av metabotropisk glutamat reseptor-5.
NO20060981L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
DK1807072T3 (da) Cycloalkyllactamderivater som inhibitorer af 11-beta-hydroxysteroid-dehydrogenase 1
NO20063355L (no) Nye trisykliske spiroderivater som modulatorer for kemokinreseptoraktivitet

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

FC2A Withdrawal, rejection or dismissal of laid open patent application